Publications

Histone methyltransferase PRDM9 promotes survival of drug-tolerant persister cells in glioblastoma

 42
Histone methyltransferase PRDM9 promotes survival of drug-tolerant persister cells in glioblastoma

Tags:

Previous Article

Driver of cardiac injury after coronary microembolization

Next Article

How glioblastoma tumors dodge chemotherapy

Related Posts

Structural pharmacology and mechanisms of GLP-1R signaling

Structural pharmacology and mechanisms of GLP-1R signaling

 157

Nuclear hormone-sensitive lipase regulates adipose tissue mass and adipocyte metabolism

Nuclear hormone-sensitive lipase regulates adipose tiss...

 66

Cell-type-specific transposon demethylation and TAD remodeling in aging mouse brain

Cell-type-specific transposon demethylation and TAD rem...

 62